Sciclone Pharma (SCLN) Reports Q4 EPS of $0.30
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Join SI Premium – FREE
Sciclone Pharma (NASDAQ: SCLN) reported Q4 EPS of $0.30, versus $0.29 reported last year. Revenue for the quarter came in at $42.9 million, versus $41.1 million reported last year.
For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- AptarGroup (ATR) Tops Q1 EPS by 11c
- South Plains Financial Inc. (SPFI) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
